Digital Edition Program

Full program details, including credit information, here

The following webinars will be presented as live or blended learning opportunities. Pre-registration is required. All webinars will be recorded and become part of the Recorded Sessions in the Digital Edition. Educational Credits are subject to change pending finalization of recordings.
Date and Time *preview of presentation materials required prior to webinar  CME | P.A.C.E.™ | NSGC
April 29
1 pm - 2:30 pm 
Paving the Path Towards a Clinical-Grade HGVS Nomenclature  1.5
May 14
1 pm - 2:30 pm
Early Career Genetic Professionals Workshop - Building Leadership/Management Skills Learn more 0
May 20
2 pm - 3:30 pm
The Genetics Hotline: Responsibility and Liability When Handling Unsolicited Patient Communications
June 4
11 am - 12 pm*
Defining Best Clinical Practices in Genomic Testing of Healthy Individuals  2.0
June 5
1 pm - 2 pm*
Genetic and Genomic Testing Outside of Clinical Care: Changing Paradigms for Access,
Application & Understanding R. Rodney Howell Symposium  
June 17
12 pm - 1:30 pm*
Short Course: Essential Fundamentals - Next Generation Sequencing From The Beginning  4.5
July 20
3:30 pm - 5:00 pm
Neurofibromatoses: New Frontiers in NF1, NF2, and Schwannomatosis REGISTER HERE 1.5

The following sessions will be available in recorded audio sync-to-slide format. Speakers and titles are subject to change:
Title  CME | P.A.C.E.™ | NSGC
Short Course: Prenatal to Postnatal Renal and Genitourinary Anomalies - Genetics, Management and Outcomes - A Joint Course
with ISPD 
ACMG Presidential Plenary Session: Mayer-Rokitansky-Kuester-Hauser (MRKH) Syndrome - A Non-lethal Birth Defect with Broad
Implications for Health Care 
TED-Style Talks - Steven Benner: Re-synthesizing Biology and from 2019, Christopher Mason: Multiomic Investigation from the Urban Biome to Outer Space and Debra Regier:  Next Generation Education Can Save Our Species 1.0
Neurogenetics Updates: What's New in Genes, Pathways, Testing, and Treatments for Intellectual Disability and Epilepsy 1.0
Cardinal Signs of Common and Uncommon Disorders 1.0
The Evolving Landscape of Delivering Genetics Services: Tangled Policies and Financial Considerations 2.0
Inherited Cancer Predisposition: Emerging Evidence to Guide Testing and Treatment Among BRCA Carriers, Lynch Syndrome
Carriers and Beyond
Classification of Constitutional Copy Number Variants: Using the Updated ACMG/ClinGen Technical Standards 1.5
Hot Topic:  Application of Immunogenomics to Cancer Therapy 0.5
Polygenic (Multifactorial) Risk Scores in Context: Utility for Clinical Practice and Population Screening 1.0
Genetic Counselor's Forum: Requesting and Working with Raw Genomic Data 1.0
Driving Precision Oncology Through Standards and Resources for Somatic Variant Interpretation 1.5
From Evidence to Guidelines: An Overview of the ACMG Evidence-Based Guidelines Program 0

OnDemand CME | P.A.C.E.™ | NSGC
Biochemical/Metabolic Genetics 1.5
Cancer Genetics and Therapeutics 1.5
Clinical Genetics and Therapeutics 1.5
Featured Platform Presentations 0.75
Genetic Counseling 1.25
Laboratory Genetics and Genomics 1.5
Legal and Ethical Issues; Education 1.25
Prenatal Genetics 1.25
Public Health, Health Services and Implementation 1.25

Sessions supported by Educational Grants. CME sponsored by a MedEd Company
Title  CME | P.A.C.E.™ | NSGC
Cases and Conversations: Patient-Minded Approaches to Managing Fabry Disease  1.5
Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid
Sphingomyelinase Deficiency 
Overcoming Barriers to Clinical Adoption of NGS:  Quality Coverage and Data Access 
Lessons Learned from Newborn Screening for Pompe Disease and Mucopolysaccharidosis Type I 
Propionic and Methylmalonic Acidemias: Defining Best Practices for Diagnosis and Treatment 
Targeting Pathogenic Mutations in the DNA Damage Response Pathway Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing 
Identifying, Assessing, and Treating Hypophosphatasia (HPP) 1.5